'Momentous Day' As FDA OKs 1st Interchangeable Biosimilar
After the U.S. Food and Drug Administration's approval Wednesday of the first-ever interchangeable biosimilar, pharmacies will automatically be able to substitute Semglee, a generic insulin medication sold by Viatris, for the...To view the full article, register now.
Already a subscriber? Click here to view full article